Optimizing the transduction efficiency of capsid-modified AAV6 serotype vectors in primary human hematopoietic stem cells in vitro and in a xenograft mouse model in vivo-Reference-Cited by-同舟云学术

Optimizing the transduction efficiency of capsid-modified AAV6 serotype vectors in primary human hematopoietic stem cells in vitro and in a xenograft mouse model in vivo

Published:2013-08 Issue:8 Volume:15 Page:986-998
ISSN:1465-3249
Container-title:Cytotherapy
language:en
Short-container-title:Cytotherapy

Author:

Song Liujiang,Kauss M. Ariel,Kopin Etana,Chandra Manasa,Ul-Hasan Taihra,Miller Erin,Jayandharan Giridhara R.,Rivers Angela E.,Aslanidi George V.,Ling Chen,Li Baozheng,Ma Wenqin,Li Xiaomiao,Andino Lourdes M.,Zhong Li,Tarantal Alice F.,Yoder Mervin C.,Wong Kamehameha K.,Tan Mengqun,Chatterjee Saswati,Srivastava Arun

Publisher

Elsevier BV

Subject

Cancer Research,Transplantation,Cell Biology,Genetics(clinical),Oncology,Immunology,Immunology and Allergy

Reference40 articles.

1. Transfusion independence and HMGA2 activation after gene therapy of human beta-thalassaemia;Cavazzana-Calvo;Nature,2010

2. Clinical gene therapy using recombinant adeno-associated virus vectors;Mueller;Gene Ther,2008

3. Therapeutic in vivo gene transfer for genetic disease using AAV: progress and challenges;Mingozzi;Nat Rev Genet,2011

4. Adeno-associated virus 2-mediated high efficiency gene transfer into immature and mature subsets of hematopoietic progenitor cells in human umbilical cord blood;Zhou;J Exp Med,1994

5. Recombinant adeno-associated virus-mediated gene transfer into hematopoietic progenitor cells;Goodman;Blood,1994

Cited by 72 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Enhanced transgene expression from single-stranded AAV vectors in human cells in vitro and in murine hepatocytes in vivo;Molecular Therapy - Nucleic Acids;2024-06

2. Enhancement of adeno‐associated virus serotype 6 transduction into T cells with cell‐penetrating peptides;The Journal of Gene Medicine;2023-11-13

3. Rational Design of AAV-rh74, AAV3B, and AAV8 with Limited Liver Targeting;Viruses;2023-10-28

4. Rationale and strategies for the development of safe and effective optimized AAV vectors for human gene therapy;Molecular Therapy - Nucleic Acids;2023-06

5. High-efficiency knock-in of degradable tags (dTAG) at endogenous loci in cell lines;Targeted Protein Degradation;2023